Baliga, R. S., Preedy, M. E. J., Dukinfield, M. S., Chu, S. M., Aubdool, A. A., Bubb, K. J., . . . Hobbs, A. J. (2018). Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure. Proc Natl Acad Sci U S A.

Baliga, Reshma S., Michael E. J. Preedy, Matthew S. Dukinfield, Sandy M. Chu, Aisah A. Aubdool, Kristen J. Bubb, Amie J. Moyes, Michael A. Tones, و Adrian J. Hobbs. "Phosphodiesterase 2 Inhibition Preferentially Promotes NO/guanylyl Cyclase/cGMP Signaling to Reverse the Development of Heart Failure." Proc Natl Acad Sci U S A 2018.

Baliga, Reshma S., et al. "Phosphodiesterase 2 Inhibition Preferentially Promotes NO/guanylyl Cyclase/cGMP Signaling to Reverse the Development of Heart Failure." Proc Natl Acad Sci U S A 2018.